DESLORATADINE Side Effects

7027289-7 | Angioedema
on Sep 23, 2010 Male patient from FRANCE , 85 years of age, was diagnosed with prostate cancer (What is prostate cancer?), hypertension, diabetes mellitus and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Desloratadine dosage: 5 Mg;qd;po. During the same period patient was treated with ESTRACYT (ESTRAMUSTINE) (ESTRAMUSTINE PHOSPHATE) (140 Mg;qd;po) (View Estracyt (estramustine) (estramustine Phosphate) Review and Estracyt (estramustine) (estramustine Phosphate) Label ), CAPTOPRIL (50 Mg;tid;po) (View Captopril Review and Captopril Label ), GABAPENTIN (100 Mg;tid;po) (View Gabapentin Review and Gabapentin Label ), ATORVASTATIN CALCIUM (80 Mg;qd;po) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), INDAPAMIDE (1.5 Mg;qd;po) (View Indapamide Review and Indapamide Label ), ACARBOSE (50 Mg;tid;po) (View Acarbose Review and Acarbose Label ), REPAGLINIDE (4 Mg;tid;po) (View Repaglinide Review and Repaglinide Label ), DILTIAZEM (300 Mg;qd;po) (View Diltiazem Review and Diltiazem Label ).

7027287-3 | Cryptorchism, Pregnancy, Umbilical Hernia
Patient was taking Desloratadine (View Usage). Patient had the following side effects: cryptorchism, pregnancy (What is pregnancy?), umbilical hernia on Sep 23, 2010 from FRANCE Additional patient health information: Male patient , weighting 5.07 lb, was diagnosed with pregnancy (What is pregnancy?) and. Desloratadine dosage: 5 Mg;qd;trpl. During the same period patient was treated with ELAVIL (10 Mg;qd;trpl) (View Elavil Review and Elavil Label ).

7016714-3 | Cholestasis, Cytolytic Hepatitis
Adverse event was reported on Sep 15, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: Po) was diagnosed with rhinitis allergic and. Location: FRANCE , child 8 years of age, After Desloratadine was administered, patient had the following side effects: cholestasis, cytolytic hepatitis. Patient was hospitalized.

7016709-X | Cytolytic Hepatitis
on Sep 10, 2010 Female patient from FRANCE , 36 years of age, was diagnosed with rhinitis allergic and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Desloratadine dosage: 5 Mg Qd Po. During the same period patient was treated with CONTRACEPTIVE (View Contraceptive Review and Contraceptive Label ).


7016654-X | Anxiety, Depression, Fatigue, Feeling Abnormal, Sedation
on Sep 17, 2010 Female patient from NORWAY , 19 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Desloratadine (View Usage). Patient had the following side effects: anxiety (What is anxiety?), depression (What is depression?), fatigue, feeling abnormal, sedation. Desloratadine dosage: Prn. During the same period patient was treated with ABILIFY (30 Mg Po; 25 Mg Po) (View Abilify Review and Abilify Label ), VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ).

7016651-4 | Anxiety, Dyspnoea Exertional, Hypersensitivity, Malaise
Patient was taking Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: anxiety (What is anxiety?), dyspnoea exertional, hypersensitivity, malaise on Sep 15, 2010 from FRANCE Additional patient health information: Female patient , 20 years of age, was diagnosed with hypersensitivity, myotonia, migraine (What is migraine?) and. Desloratadine dosage: Po. During the same period patient was treated with MEXITIL (Po) (View Mexitil Review and Mexitil Label ), LOPRESSOR (Po) (View Lopressor Review and Lopressor Label ), ATARAX (Po) (View Atarax Review and Atarax Label ), ZOMIG (View Zomig Review and Zomig Label ), MAXALT (View Maxalt Review and Maxalt Label ), BOTOX (View Botox Review and Botox Label ). Patient was hospitalized.

7016645-9 | Anxiety, Dyspnoea, Feeling Abnormal, Gastroenteritis, Hypokalaemia, Malaise, Syncope
Adverse event was reported on Sep 15, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: Po) was diagnosed with hypersensitivity, myotonia and. Location: FRANCE , 19 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, feeling abnormal, gastroenteritis (What is gastroenteritis?), hypokalaemia, malaise, syncope. During the same period patient was treated with MEXITIL (Po) (View Mexitil Review and Mexitil Label ), ZOMIG (View Zomig Review and Zomig Label ), MAXALT (View Maxalt Review and Maxalt Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), BOTOX (View Botox Review and Botox Label ). Patient was hospitalized.

7016464-3 | Cytolytic Hepatitis, Hepatitis Cholestatic
on Sep 15, 2010 Female patient from FRANCE , child 12 years of age, was diagnosed with solar urticaria and was treated with Desloratadine (View Usage). Patient had the following side effects: cytolytic hepatitis, hepatitis cholestatic. Desloratadine dosage: ; Po. Patient was hospitalized.

7016457-6 | Asthenia, Back Pain, Decreased Appetite, Dry Mouth, Dyspnoea, Headache, Pain In Extremity, Somnolence
on Sep 15, 2010 Male patient from BELGIUM , 47 years of age, weighting 147.7 lb, was diagnosed with seasonal allergy and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: asthenia, back pain (What is back pain?), decreased appetite, dry mouth, dyspnoea, headache (What is headache?), pain in extremity, somnolence. Desloratadine dosage: 1 Df; Qd;. During the same period patient was treated with TAMSULOSINE 0.4 (View Tamsulosine 0.4 Review and Tamsulosine 0.4 Label ).

7008797-1 | Atrial Fibrillation, Cardio-respiratory Arrest
Patient was taking Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), cardio-respiratory arrest on Sep 16, 2010 from FRANCE Additional patient health information: Female patient , 40 years of age, . Desloratadine dosage: 5 Mg;po. During the same period patient was treated with CELESTAMINE TAB (Po) (View Celestamine Tab Review and Celestamine Tab Label ), AZELASTINE HCL (Oph) (View Azelastine Hcl Review and Azelastine Hcl Label ), SYMBICORT (Inh) (View Symbicort Review and Symbicort Label ).

7008738-7 | Hallucination, Visual, Mydriasis
Adverse event was reported on Sep 14, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: .5 Ml;qd;) was diagnosed with urticaria and. Location: BELGIUM , child 2 years of age, Patient had the following side effects: hallucination, visual, mydriasis.

7006406-9 | Hallucination
on Sep 01, 2010 Female patient from EGYPT , child 11 years of age, weighting 110.2 lb, was diagnosed with rhinitis allergic and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: hallucination. Desloratadine dosage: ; Qd; Po. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), RHINOCORT (View Rhinocort Review and Rhinocort Label ), SYMBICORT (View Symbicort Review and Symbicort Label ).

6980212-3 | Feeling Abnormal, Sedation
on Aug 31, 2010 Female patient from NORWAY , 20 years of age, was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: feeling abnormal, sedation. Desloratadine dosage: . During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

6959552-X | Abdominal Discomfort, Diarrhoea, Epileptic Aura, Fatigue, Headache, Hot Flush, Myalgia, Nausea
Patient was taking Desloratadine (View Usage). Patient had the following side effects: abdominal discomfort, diarrhoea, epileptic aura, fatigue, headache (What is headache?), hot flush, myalgia, nausea (What is nausea?) on Aug 17, 2010 from SWEDEN Additional patient health information: Female patient , 32 years of age, was diagnosed with seasonal allergy and. Desloratadine dosage: 1 Df;qd. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ).

6959550-6 | Blood Cholesterol Increased, Blood Triglycerides Increased
Adverse event was reported on Aug 23, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: 5 Mg;qd;po) was diagnosed with rhinitis allergic and. Location: FRANCE , 42 years of age, After Desloratadine was administered, patient had the following side effects: blood cholesterol increased, blood triglycerides increased. During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ).

6926267-3 | Lichenoid Keratosis, Prurigo, Toxic Skin Eruption
on Aug 02, 2010 Male patient from FRANCE , 92 years of age, was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis, prurigo, toxic skin eruption. Desloratadine dosage: ; Po. During the same period patient was treated with XATRAL (ALFUZOSIN) (2.5 Mg; Po) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (75 Mg; Po) (View Kardegic (acetylsalicylate Lysine) Review and Kardegic (acetylsalicylate Lysine) Label ), SPIRONOLACTONE (50 Mg; Po) (View Spironolactone Review and Spironolactone Label ), ESCITALOPRAM (10 Mg; ; Po) (View Escitalopram Review and Escitalopram Label ), ATARAX (25 Mg; ; Po) (View Atarax Review and Atarax Label ), PANTOPRAZOLE (20 Mg; Po) (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6925568-2 | Dyspnoea Exertional, Malaise
on Aug 03, 2010 Female patient from FRANCE , 20 years of age, was diagnosed with hypersensitivity, myotonia, migraine (What is migraine?) and was treated with Desloratadine (View Usage). Patient had the following side effects: dyspnoea exertional, malaise. Desloratadine dosage: Po. During the same period patient was treated with MEXITIL (Po) (View Mexitil Review and Mexitil Label ), LOPRESSOR (Po) (View Lopressor Review and Lopressor Label ), ATARAX (Po) (View Atarax Review and Atarax Label ), ZOMIG (View Zomig Review and Zomig Label ), MAXALT (View Maxalt Review and Maxalt Label ), BOTOX (View Botox Review and Botox Label ). Patient was hospitalized.

6924464-4 | Cerebral Infarction, Cerebrovascular Accident, Hypersensitivity
Patient was taking Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: cerebral infarction, cerebrovascular accident, hypersensitivity on Aug 03, 2010 from GERMANY Additional patient health information: Male patient , 40 years of age, was diagnosed with hypersensitivity and. Desloratadine dosage: Qd. Patient was hospitalized.

6924462-0 | Feeling Abnormal, Malaise, Syncope
Adverse event was reported on Aug 03, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: Po) was diagnosed with hypersensitivity, myotonia and. Location: FRANCE , 19 years of age, Patient experienced the following unwanted or unexpected effects: feeling abnormal, malaise, syncope. During the same period patient was treated with MEXITIL (Po) (View Mexitil Review and Mexitil Label ), ZOMIG (View Zomig Review and Zomig Label ), MAXALT (View Maxalt Review and Maxalt Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), BOTOX (View Botox Review and Botox Label ). Patient was hospitalized.

6924460-7 | Choking Sensation, Rash
on Jul 30, 2010 Male patient from ITALY , 53 years of age, was diagnosed with hypersensitivity and was treated with Desloratadine (View Usage). Patient had the following side effects: choking sensation, rash (What is rash?). Desloratadine dosage: 5 Mg Qd Po.

6920199-2 | Erythema, Rash Morbilliform, Rash Pustular, Skin Exfoliation
on Aug 02, 2010 Female patient from FRANCE , 37 years of age, was diagnosed with grand mal convulsion, cough, pyrexia and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: erythema, rash morbilliform, rash pustular, skin exfoliation. Desloratadine dosage: Po. During the same period patient was treated with DEPAKENE (View Depakene Review and Depakene Label ), AUGMENTIN '125' (3 Gm;qm;po) (View Augmentin '125' Review and Augmentin '125' Label ), TRAMADOL HCL (Po) (View Tramadol Hcl Review and Tramadol Hcl Label ), ROVAMYCINE (SPIRAMYCIN) (Po) (View Rovamycine (spiramycin) Review and Rovamycine (spiramycin) Label ), DIVARIUS (View Divarius Review and Divarius Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ). Patient was hospitalized.

6920191-8 | Condition Aggravated, Lichenoid Keratosis, Prurigo, Toxic Skin Eruption
Patient was taking Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, lichenoid keratosis, prurigo, toxic skin eruption on Aug 02, 2010 from FRANCE Additional patient health information: Male patient , 92 years of age, . Desloratadine dosage: Po. During the same period patient was treated with XATRAL (ALFUZOSIN) (2.5 Mg; Po) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), KARDEGIC (ACETYLSALICYLATE LYSINE) (75 Mg; Po) (View Kardegic (acetylsalicylate Lysine) Review and Kardegic (acetylsalicylate Lysine) Label ), SPIRONOLACTONE (50 Mg; Po) (View Spironolactone Review and Spironolactone Label ), ESCITALOPRAM (10 Mg; Po) (View Escitalopram Review and Escitalopram Label ), ATARAX (25 Mg; Po) (View Atarax Review and Atarax Label ), PANTOPRAZOLE (20 Mg;po) (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6916658-9 | Blood Cholesterol Abnormal, Blood Triglycerides Abnormal
Adverse event was reported on Jul 30, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: ) . Location: FRANCE , 42 years of age, Patient had the following side effects: blood cholesterol abnormal, blood triglycerides abnormal. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6915568-0 | Dysgeusia, Product Quality Issue, Throat Irritation
on Jul 28, 2010 Male patient from PORTUGAL , 44 years of age, weighting 224.9 lb, was diagnosed with nasal congestion and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: dysgeusia, product quality issue, throat irritation. Desloratadine dosage: 5 Mg; Po. During the same period patient was treated with AMOXICILLIN (CON.) (View Amoxicillin (con.) Review and Amoxicillin (con.) Label ).

6819000-7 | Abnormal Behaviour, Aggression, Hallucination, Incoherent
on Jun 29, 2010 Male patient from FRANCE , 14 years of age, weighting 85.98 lb, was diagnosed with rhinitis perennial and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, aggression, hallucination, incoherent. Desloratadine dosage: 1 Df; Qd; Po. During the same period patient was treated with SERETIDE (View Seretide Review and Seretide Label ), NASONEX (View Nasonex Review and Nasonex Label ).

6815335-2 | Hallucination, Visual
Patient was taking Desloratadine (View Usage). Patient had the following side effects: hallucination, visual on Jun 21, 2010 from FRANCE Additional patient health information: Male patient , child 5 years of age, was diagnosed with urticaria and. Desloratadine dosage: 5 Ml;qd; Po, 2.5 Ml;qd;po. During the same period patient was treated with PRIMALAN (View Primalan Review and Primalan Label ).

6800350-5 | Product Substitution Issue, Product Taste Abnormal, Throat Irritation
Adverse event was reported on Jun 09, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: 5 Mg; Po) was diagnosed with nasal congestion and. Location: PORTUGAL , 44 years of age, weighting 224.9 lb, After Desloratadine was administered, patient had the following side effects: product substitution issue, product taste abnormal, throat irritation. During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ).

6800187-7 | Oral Discomfort, Stomatitis, Throat Irritation
on Jun 09, 2010 Female patient from PORTUGAL , 53 years of age, weighting 154.3 lb, was diagnosed with nasal congestion and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: oral discomfort, stomatitis, throat irritation. Desloratadine dosage: 5 Mg; ; Po.

6773281-7 | Hepatitis, Pancreatitis
on Jun 08, 2010 Male patient from GERMANY , 35 years of age, weighting 209.4 lb, was diagnosed with seasonal allergy and was treated with Desloratadine (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?), pancreatitis. Desloratadine dosage: 5 Mg;qd;po. Patient was hospitalized.

6771521-1 | Deafness Transitory
Patient was taking Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: deafness transitory on Jun 03, 2010 from GREECE Additional patient health information: Male patient , 15 years of age, weighting 121.3 lb, was diagnosed with rhinitis allergic, lower respiratory tract infection and. Desloratadine dosage: 7 Ml;qd;po. During the same period patient was treated with CLARITHROMYCIN (250 Mg;bid;po) (View Clarithromycin Review and Clarithromycin Label ), SINGULAIR (View Singulair Review and Singulair Label ), FLIXOTIDE (View Flixotide Review and Flixotide Label ).

6771456-4 | Lip Swelling, Swelling Face
Adverse event was reported on May 28, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: 5 Mg;once;po) . Location: CANADA , 74 years of age, Patient experienced the following unwanted or unexpected effects: lip swelling, swelling face. During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ATROVENT (View Atrovent Review and Atrovent Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ELAVIL (View Elavil Review and Elavil Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), VENTOLIN HFA (View Ventolin Hfa Review and Ventolin Hfa Label ).

6769327-2 | Hypoaesthesia, Insomnia, Psychomotor Hyperactivity, Speech Disorder
on May 28, 2010 Male patient from CANADA , 40 years of age, was treated with Desloratadine (View Usage). Patient had the following side effects: hypoaesthesia, insomnia, psychomotor hyperactivity, speech disorder. Desloratadine dosage: 5 Mg; Qd; Po. During the same period patient was treated with SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ).

6769148-0 | Condition Aggravated, Dyspnoea, Eye Oedema, Hypersensitivity, Nasal Oedema, Pharyngeal Oedema, Product Substitution Issue, Rhinitis
on May 31, 2010 Male patient from FRANCE , child 12 years of age, was diagnosed with rhinitis seasonal and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: condition aggravated, dyspnoea, eye oedema, hypersensitivity, nasal oedema, pharyngeal oedema, product substitution issue, rhinitis. Desloratadine dosage: Po; 5 Mg;qd;po.

6769103-0 | Agitation, Dizziness, Hallucination, Hyperhidrosis, Nightmare, Palpitations, Vision Blurred
Patient was taking Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, dizziness (What is dizziness?), hallucination, hyperhidrosis, nightmare, palpitations, vision blurred on May 28, 2010 from CANADA Additional patient health information: Male patient , 17 years of age, weighting 141.1 lb, was diagnosed with seasonal allergy and. Desloratadine dosage: 5 Mg; Qd; Po.

6769091-7 | Alcohol Interaction, Alcohol Poisoning, Feeling Drunk
Adverse event was reported on May 28, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: 5 Mg; Qd; Po) was diagnosed with multiple allergies and. Location: CANADA , 50 years of age, Patient had the following side effects: alcohol interaction, alcohol poisoning, feeling drunk.

6761367-2 | Headache, Hypoaesthesia, Insomnia, Psychomotor Hyperactivity, Speech Disorder
on May 28, 2010 Male patient from CANADA , 40 years of age, was diagnosed with rhinitis allergic and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: headache (What is headache?), hypoaesthesia, insomnia, psychomotor hyperactivity, speech disorder. Desloratadine dosage: 5 Mg;qd;po. During the same period patient was treated with SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ).

6761365-9 | Disorientation, Lacrimation Increased, Nasal Congestion, Product Quality Issue, Somnolence
on May 28, 2010 Female patient from CANADA , 35 years of age, weighting 138.9 lb, was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, lacrimation increased, nasal congestion, product quality issue, somnolence. Desloratadine dosage: 5 Mg;qd;po.

6754982-3 | Abnormal Dreams, Eye Pruritus, Hallucination, Nasal Congestion, Rhinorrhoea, Sneezing
Patient was taking Desloratadine (View Usage). Patient had the following side effects: abnormal dreams, eye pruritus, hallucination, nasal congestion, rhinorrhoea, sneezing on May 28, 2010 from CANADA Additional patient health information: Female patient , 28 years of age, was diagnosed with rhinitis seasonal and. Desloratadine dosage: 5 Mg;prn;po. During the same period patient was treated with CONTRACEPTIVES (View Contraceptives Review and Contraceptives Label ).

6754980-X | Hallucination
Adverse event was reported on May 27, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: 2.5 Ml;qd;po) was diagnosed with urticaria and. Location: FRANCE , child 5 years of age, After Desloratadine was administered, patient had the following side effects: hallucination. During the same period patient was treated with PRIMALAN (View Primalan Review and Primalan Label ).

6743476-7 | Eye Swelling, Swelling Face, Tablet Issue
on May 06, 2010 Female patient from PORTUGAL , 48 years of age, was diagnosed with nasal congestion and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: eye swelling, swelling face, tablet issue. Desloratadine dosage: 5 Mg;. During the same period patient was treated with NIMED (View Nimed Review and Nimed Label ).

6742176-7 | Dermatitis Allergic
on May 18, 2010 Female patient from INDONESIA , 25 years of age, was diagnosed with dermatitis and was treated with Desloratadine (View Usage). Patient had the following side effects: dermatitis allergic. Desloratadine dosage: 5 Mg;qd;po. Patient was hospitalized.

6740420-3 | Cholestasis, Cytolytic Hepatitis
Patient was taking Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: cholestasis, cytolytic hepatitis on May 17, 2010 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with influenza, gastrooesophageal reflux disease, intestinal functional disorder and. Desloratadine dosage: Po. During the same period patient was treated with RABEPRAZOLE SODIUM (Po) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), EXOMUC (ACETYLCYSSTEINE) (Po) (View Exomuc (acetylcyssteine) Review and Exomuc (acetylcyssteine) Label ), POLERY ADULTE (PULERY) 01710801/) (Po) (View Polery Adulte (pulery) 01710801/) Review and Polery Adulte (pulery) 01710801/) Label ), TRIMEBUTINE (TRIMESBUTINE) (Po) (View Trimebutine (trimesbutine) Review and Trimebutine (trimesbutine) Label ). Patient was hospitalized.

6733085-8 | Dermatitis Allergic
Adverse event was reported on May 04, 2010 by a Female patient taking Desloratadine (View Usage) (Dosage: 5 Mg;qd;po) was diagnosed with dermatitis and. Location: INDONESIA , 25 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis allergic. Patient was hospitalized.

6729774-1 | Condition Aggravated, Dyspnoea, Eye Oedema, Nasal Oedema, Pharyngeal Oedema, Rhinitis
on May 07, 2010 Male patient from FRANCE , child 12 years of age, was diagnosed with rhinitis seasonal and was treated with Desloratadine (View Usage). Patient had the following side effects: condition aggravated, dyspnoea, eye oedema, nasal oedema, pharyngeal oedema, rhinitis. Desloratadine dosage: Po ; 5 Mg;qd;po.

6729762-5 | Crying, Eye Pain, Headache, Myositis, Productive Cough, Pyrexia
on May 12, 2010 Male patient from FRANCE , weighting 52.91 lb, was diagnosed with seasonal allergy and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: crying, eye pain, headache (What is headache?), myositis (What is myositis?), productive cough, pyrexia. Desloratadine dosage: 5 Ml;qpm;po ; 5 Ml;qpm;po. During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ), JOSACINE (View Josacine Review and Josacine Label ).

6713862-X | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatine Increased, Cardiac Arrest, Cerebral Ischaemia, Confusional State, Diarrhoea
Patient was taking Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatine increased, cardiac arrest (What is cardiac arrest?), cerebral ischaemia, confusional state, diarrhoea on Apr 28, 2010 from FRANCE Additional patient health information: Female patient , 75 years of age, . Desloratadine dosage: 5 Mg; Qd; Po. During the same period patient was treated with EXJADE (ANTIDOTES) (2 Df; Qd; Po) (View Exjade (antidotes) Review and Exjade (antidotes) Label ), NEORECORMON (EPOETIN BETA) (View Neorecormon (epoetin Beta) Review and Neorecormon (epoetin Beta) Label ), BETAHISTINE (BETAHISTINE /00141801/) (8 Mg; Qd; Po) (View Betahistine (betahistine /00141801/) Review and Betahistine (betahistine /00141801/) Label ), EFFERALGAN (PARACETAMOL /00020001/) (1 Gm; Prn; Po) (View Efferalgan (paracetamol /00020001/) Review and Efferalgan (paracetamol /00020001/) Label ), FLUIDABAK (POLYVIDONE) (; Oph) (View Fluidabak (polyvidone) Review and Fluidabak (polyvidone) Label ), CROMABAK (CROMOGLICATE SODIUM) (; Oph) (View Cromabak (cromoglicate Sodium) Review and Cromabak (cromoglicate Sodium) Label ). Patient was hospitalized.

6703717-9 | Pruritus, Pyrexia, Rash Pustular
Adverse event was reported on Apr 22, 2010 by a Male patient taking Desloratadine (View Usage) (Dosage: 5 Mg;bid;) . Location: AUSTRIA , 70 years of age, weighting 185.2 lb, Patient had the following side effects: pruritus, pyrexia, rash pustular. During the same period patient was treated with AMLODIPIN BESILAT (View Amlodipin Besilat Review and Amlodipin Besilat Label ), MAGNESIUM VERLA (View Magnesium Verla Review and Magnesium Verla Label ), PROSTADILAT (View Prostadilat Review and Prostadilat Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

6703493-X | Petechiae, Vasculitis
on Apr 23, 2010 Male patient from FINLAND , child 8 years of age, weighting 70.55 lb, was diagnosed with seasonal allergy and was treated with Desloratadine (View Usage). After Desloratadine was administered, patient had the following side effects: petechiae, vasculitis (What is vasculitis?). Desloratadine dosage: 2.5 Mg; ;po.

6703492-8 | Extrapyramidal Disorder, Musculoskeletal Stiffness, Myalgia
on Apr 22, 2010 Female patient from FRANCE , 46 years of age, was diagnosed with urticaria chronic and was treated with Desloratadine (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, musculoskeletal stiffness, myalgia. Desloratadine dosage: 1 Df;qd;po. During the same period patient was treated with ATARAX (25 Mg;qd;po, 25 Mg;qd;po) (View Atarax Review and Atarax Label ).

6703464-3 | Crying, Headache, Myositis, Pyrexia
Patient was taking Desloratadine (View Usage). Patient had the following side effects: crying, headache (What is headache?), myositis (What is myositis?), pyrexia on Apr 22, 2010 from FRANCE Additional patient health information: Male patient , child 7 years of age, was diagnosed with seasonal allergy and. Desloratadine dosage: 5 Ml; Qpm; Po. During the same period patient was treated with CLAMOXYL (View Clamoxyl Review and Clamoxyl Label ).